Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for ABEO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 57.23M
March 31, 2026 56.87M
December 31, 2025 55.04M
September 30, 2025 52.40M
June 30, 2025 51.25M
March 31, 2025 48.95M
December 31, 2024 45.64M
September 30, 2024 43.40M
June 30, 2024 41.66M
March 31, 2024 27.55M
December 31, 2023 26.52M
September 30, 2023 24.71M
June 30, 2023 21.48M
March 31, 2023 17.93M
December 31, 2022 17.72M
September 30, 2022 7.671M
June 30, 2022 5.870M
March 31, 2022 5.883M
December 31, 2021 5.888M
September 30, 2021 4.075M
June 30, 2021 4.05M
March 31, 2021 3.962M
December 31, 2020 3.845M
September 30, 2020 3.381M
June 30, 2020 3.391M
Date Value
March 31, 2020 3.345M
December 31, 2019 3.345M
September 30, 2019 2.042M
June 30, 2019 1.97M
March 31, 2019 1.918M
September 30, 2018 1.918M
June 30, 2018 1.893M
March 31, 2018 1.889M
December 31, 2017 1.876M
September 30, 2017 1.637M
June 30, 2017 1.612M
March 31, 2017 1.610M
December 31, 2016 1.610M
September 30, 2016 1.348M
June 30, 2016 1.312M
March 31, 2016 1.310M
December 31, 2015 1.310M
September 30, 2015 1.309M
June 30, 2015 1.194M
March 31, 2015 0.80M
December 31, 2014 0.7984M
September 30, 2014 0.0214M
June 30, 2014 0.0212M
March 31, 2014 0.0208M
December 31, 2013 0.0206M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Corcept Therapeutics, Inc. 107.92M
Forum Markets, Inc. 13.21M
ACADIA Pharmaceuticals, Inc. 172.13M
Alnylam Pharmaceuticals, Inc. 133.73M
Anika Therapeutics, Inc. 13.38M